Atlas / Countries
Thirty markets
Every EU member state plus the UK, Switzerland and Norway. The bar under each card is the six-axis profile at a glance, green is open, red is closed. Six markets are on the shortlist and are marked and sorted first: the United Kingdom, Germany, Switzerland, Denmark, Norway and Sweden.
Western Europe
shortlistSwitzerland3.9Ownership is fully open, mail order works, and a genuine domestic operator now exists in ViaSlim, backed by Redcare’s licensed distribution. The catches are that Swissmedic polices advertising harder than any EU regulator including against journalism, which forces every operator to choose between naming the drug and staying safe; reimbursed prescribing is gated to specialists with patient-volume thresholds; and neither oral drug is authorised here. Romandie and Ticino have no native operator at all.researchednon-EUshortlistUnited Kingdom3.9The most developed private GLP-1 market in Europe and the easiest to set up in legally, a non-pharmacist can own the pharmacy outright, but advertising a prescription medicine to the public is a criminal offence, margins are negative at the doses patients titrate to without a manufacturer deal, and the incumbents have raised £45–150m each.researchednon-EUshortlistGermany3.0The biggest private GLP-1 market in Europe and the one every cross-border structure is pointed at, but you can never own the pharmacy, a German pharmacy cannot legally discount, and two courts have already enjoined the questionnaire-and-advertise model everyone uses.researchedIreland3.8The best English-language EU beachhead: a limited company can own the pharmacy, remote prescribing is the working norm with no in-person mandate, and there is essentially no state cover for weight-management GLP-1s, but HPRA seizures of counterfeit product rose thirty-fold in a year and the regulator opened a social-media advertising push in May 2026.researchedNetherlands3.5The jurisdiction every European cross-border structure runs through, because it is the one place you can own the pharmacy outright and legally post prescriptions, but the prescribing model everyone uses rests on a revocable ministerial policy, and the inspectorate is currently investigating ten of the companies using it.researchedBelgium2.9Ownership is genuinely open and the minister formally refused to reimburse Wegovy in June 2026, leaving a wholly cash-pay obesity market. But the borders are closed, no major pan-EU telehealth brand serves Belgium, and medical deontology rules out cold-start questionnaire consultations.researchedAustria2.3The received wisdom that Austria requires in-person first contact is wrong: telemedicine has been explicitly lawful since January 2024 and fully remote private-pay clinics operate openly. The real blocks are a personal, non-transferable pharmacy licence and an outright ban on posting prescription medicines.researchedFrance2.3Commercially the most exciting continental market, any doctor has been able to prescribe since June 2025 and reimbursement arrived in June 2026, and by a distance the most aggressively policed: ANSM fined Novo Nordisk €1.78m and Eli Lilly €108,766 in April 2026 for obesity-awareness campaigns it read as indirect advertising.researchedLuxembourg1.6The most closed market in the atlas, and for a reason found nowhere else. A Luxembourg pharmacy is not a business you can buy: it is a public service held under a personal concession that extinguishes when the holder turns seventy or dies. The Ministry states there is no plan to permit prescription distance selling. There is no e-prescription system, and the payer refuses electronic proof of prescription.researched
Nordic Europe
shortlistSweden4.5On the structural axes that matter, the most open market in Europe: anyone can obtain a pharmacy licence, prescription mail order is legal and normal, and TLV rejected Wegovy from reimbursement in February 2026, leaving a fully cash-pay market that 2.5% of the population is already in.researchedshortlistDenmark3.9A large, sophisticated, fully cash-pay DTC market, and the one Nordic market with a genuinely domestic category leader rather than a pan-European one. You can never own the pharmacy end, because Denmark kept its pharmacist-only concession system under apotekerloven §15, and that turns out to be the moat: Aposund now runs in-person weighing at more than 170 physical pharmacy counters in partnership with Danmarks Apotekerforening, at 140 DKK per four weeks, a price no pure-digital entrant can match. Marketing is the hardest problem here, because Denmark bans video marketing of health services off your own site regardless of whether the drug is named.researchedshortlistNorway3.9Exceptional demand behind a closed door. Roughly NOK 2.6bn is spent out of pocket across 5.6m people, several times the Swedish figure per head, and the only reimbursement pathway is a narrow subgroup the Storting still has not funded. But inbound cross-border supply is flatly banned, more than 90 per cent of pharmacies sit in three chains, and DMP has now issued a stop order against a weight-loss telehealth operator. Our earlier score of 4.3 was too generous and has been marked down.researchednon-EUFinland3.3Prescribing is genuinely liberal, mail order is legal, and 108,000 Finns bought obesity medication in 2025 paying 84m of 90m euros themselves. The hard block is ownership: only a licensed proviisori may hold a pharmacy licence, and the 2025 reform package deliberately left that untouched.researched
Southern Europe
Portugal4.0The most commercially open market in southern Europe: companies can own up to four pharmacies outright, telehealth operators run a working e-prescription channel, and Portuguese consumers spent 55.2m euros on these drugs in the first quarter of 2026 alone. Reimbursement for obesity is still pending and now depends on a whole new evaluation system being built first.researchedItaly2.7The most capital-friendly ownership regime of the southern markets, capital companies have been able to own pharmacies since 2017, paired with the hardest operational barrier: Rx mail order is flatly prohibited and dematerialised e-prescriptions have not changed that. A workable business here is click-and-mortar, not remote fulfilment.researchedCroatia2.6A correction page. The frequently cited article 38 ownership threshold in the Zakon o ljekarništvu does not exist: article 38 concerns Chamber finances. The current text contains no ownership cap, which makes Croatia considerably more open than it is usually described. Mail order remains firmly over-the-counter only under the July 2025 Pravilnik.researchedSlovenia2.5A small market with a disproportionately visible self-pay GLP-1 segment: six of the top ten self-pay best-selling medicines contain semaglutide or tirzepatide, and around a fifth of GLP-1 prescriptions are white-prescription self-pay. Ownership is effectively closed to private capital because pharmacies are a municipal public service, and JAZMP’s enforcement record against online sellers is a warning rather than a deterrent.researchedSpain2.1A large, mature, entirely cash-pay market behind two hard structural walls: only individual pharmacists may own a pharmacy, and mail-order dispensing of prescription medicines is explicitly illegal. The workable model, Spain-colegiado doctors prescribing into independent licensed pharmacies, already operates at scale.researched
Central Europe
Poland3.2The most commercially alive Central European market: a mature "receptomat" industry already sells GLP-1 prescriptions at scale, obesity gets no reimbursement at all, and a June 2025 CJEU ruling gutted the historic pharmacy advertising ban, but you cannot own the dispensing pharmacy and Rx mail order stays illegal, so fulfilment is click-and-collect.researchedCzechia2.9Ownership is genuinely open and now citable: a legal entity may hold the pharmacy licence provided it appoints a professional representative. What kills the DTC model is dispensing, not ownership. SÚKL guidance LEK-16 excludes prescription medicines from mail order entirely, and eRecepty are redeemed in person, which is why Czechia has no receptomat market despite sitting next door to Poland.researchedSlovakia2.9This page previously recorded Slovakia as pharmacist-only ownership. That was wrong and is corrected here: a legal entity may hold the licence with an odborný zástupca, which is why Dr.Max and BENU run chains. Wegovy has official Novo Nordisk list prices from 1 February 2026, the whole obesity market is cash, and the constraint is the same as Czechia’s, namely that prescription mail order is closed.researchedHungary2.6Ownership is majority-pharmacist by statute, which blocks the clean structure, but the more interesting finding is how the working DTC operator gets around the prescription layer: Hi-Doctor issues Spanish REMPE cross-border prescriptions rather than Hungarian EESZT ones. Everything for obesity is cash. The March 2026 GVH fine that circulates as GLP-1 enforcement was about a probiotic.researched
Baltic Europe
Lithuania3.5The most consequential correction on this site. Lithuania has permitted prescription mail order since 12 July 2022, with nineteen registered remote pharmacies, which means the widely cited list of seven EU states allowing Rx mail order is incomplete. Ownership is open, the market is small, and Dokteronline is not licensed here despite appearances.researchedEstonia3.1The best digital prescription infrastructure in Europe attached to the strictest ownership review. Estonia’s digiretsept is now recognised in ten other countries, which makes it a genuinely interesting prescribing origin, but the 2021 Supreme Court rulings force a substance-over-form test on pharmacy ownership that defeats the usual nominee structures.researchedLatvia2.7The ownership rule is more permissive than it looks, and the detail is the word "or". Article 36(2) of the Farmācijas likums is satisfied either by a pharmacist holding half the shares **or** by pharmacists making up half the board, which means a corporate group can comply with no pharmacist equity at all. Everything else is closed: prescription mail order is unlawful, obesity is not a reimbursable diagnosis in any form, and the reimbursed diabetes route carries a hard stopping rule.researched
South-eastern Europe
Greece3.0A state-funded scheme covering 43,500 patients with BMI 37 and very high cardiovascular risk, whose EU funding collapsed mid-2026 and is being moved onto the state budget. Ownership was tightened in May 2026, and no pan-EU telehealth brand serves Greece at all.researchedRomania2.8The most interesting of the six markets that were stubs. No ownership restriction, no chain cap, a statutory telemedicine framework in force since November 2020 whose definition of teleconsultation expressly includes indicating treatment, nineteen million people, official published maximum prices, and no obesity reimbursement. What closes the loop is dispensing: online sale is non-prescription only, with fines to 100,000 lei.researchedBulgaria2.1Open on who may own, capped hard on how many: any EU-registered trader may run a pharmacy, but no person may hold more than four. The more distinctive feature is the export-control machine. Bulgaria runs a weekly-updated statutory export prohibition, expressly covering supply to other member states, triggered when domestic stock falls below 65% of a month’s demand. Whether GLP-1s are caught depends on a Positive Drug List entry that could not be confirmed.researched
Islands Europe
Malta3.1The second correction that changes a headline. Malta is on every published list of EU states permitting prescription mail order, and the Malta Medicines Authority’s own register page says the opposite: Maltese law does not provide for the establishment of internet pharmacies at all, and none exist. What Malta does have is the most open ownership rule of any small EU state, the highest obesity prevalence in the EU, and two thirds of the population already paying cash for outpatient medicines.researchedCyprus1.8Closed on every axis that matters. A hard statutory cap of one pharmacy per owner rules out chains entirely, distance selling expressly excludes prescription medicines, and the only electronic prescriptions a Cypriot pharmacy may dispense are those retrieved from the state health system. A cross-border prescription has to arrive on signed paper. There is no shape of DTC business that fits.researched